Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Neoplasms of the CNS

  Free Subscription


28.09.2020

1 BMC Cancer
1 Cancer Res
1 Clin Cancer Res
3 J Neurooncol
2 J Neuropathol Exp Neurol
1 Neuro Oncol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. VUONG HG, Nguyen TQ, Ngo TNM, Nguyen HC, et al
    The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis.
    BMC Cancer. 2020;20:897.
    PubMed         Abstract available


    Cancer Res

  2. SUBRAMANI E, Radoul M, Najac C, Batsios G, et al
    Glutamate is a non-invasive metabolic biomarker of IDH1 mutant glioma response to temozolomide treatment.
    Cancer Res. 2020 Sep 21. pii: 0008-5472.CAN-20-1314.
    PubMed         Abstract available


    Clin Cancer Res

  3. WIRSCHING HG, Roelcke U, Weller J, Hundsberger T, et al
    MRI and 18FET-PET predict survival benefit from bevacizumab plus radiotherapy in patients with IDH wild-type glioblastoma: results from the randomized ARTE trial.
    Clin Cancer Res. 2020 Sep 23. pii: 1078-0432.CCR-20-2096.
    PubMed         Abstract available


    J Neurooncol

  4. KHALAFALLAH AM, Jimenez AE, Patel P, Huq S, et al
    A novel online calculator predicting short-term postoperative outcomes in patients with metastatic brain tumors.
    J Neurooncol. 2020 Sep 22. pii: 10.1007/s11060-020-03626.
    PubMed         Abstract available

  5. SENFT C, Behrens M, Lortz I, Wenger K, et al
    The ability to return to work: a patient-centered outcome parameter following glioma surgery.
    J Neurooncol. 2020 Sep 22. pii: 10.1007/s11060-020-03609.
    PubMed         Abstract available

  6. KHAN AB, Gadot R, Shetty A, Bayley JC 5th, et al
    Identification of novel fusion transcripts in meningioma.
    J Neurooncol. 2020 Sep 19. pii: 10.1007/s11060-020-03599.
    PubMed         Abstract available


    J Neuropathol Exp Neurol

  7. MORRIS M, Driscoll M, Henson JW, Cobbs C, et al
    Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    J Neuropathol Exp Neurol. 2020;79:1038-1043.
    PubMed         Abstract available

  8. RICHARDSON TE, Kumar A, Xing C, Hatanpaa KJ, et al
    Overcoming the Odds: Toward a Molecular Profile of Long-Term Survival in Glioblastoma.
    J Neuropathol Exp Neurol. 2020;79:1031-1037.
    PubMed         Abstract available


    Neuro Oncol

  9. SHIREMAN JM, Ahmed AU
    Separate and not Equal: Sex Differences in JAM-A Tumor Suppression in Glioblastoma.
    Neuro Oncol. 2020 Sep 22. pii: 5909858. doi: 10.1093.
    PubMed        


    PLoS One

  10. PRUTEANU LL, Kopanitsa L, Modos D, Kletnieks E, et al
    Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells.
    PLoS One. 2020;15:e0239551.
    PubMed         Abstract available

  11. ROSIAK-STEC K, Grot D, Rieske P
    Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing.
    PLoS One. 2020;15:e0239325.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: